Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
AdvanCell
company
About
AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
- Sydney,New South Wales,Australia
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $18M
- Industries
- Biotechnology,Clinical Trials,Pharmaceutical
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- AdvanCell Isotopes Pty Ltd.
AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$18M $2.10M
AdvanCell has raised a total of
$18M $2.10M
in funding over 2 rounds. Their latest funding was raised on
Aug 23, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 23, 2022 | Series B | $18M | 1 |
Morningside Venture Investments
|
— | Detail |
| Dec 23, 2021 | Grant | $2.10M | 1 |
NSW Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
AdvanCell is funded by 2 investors.
Morningside Venture Investments
and NSW Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Morningside Venture Investments
|
Yes | Series B |
|
NSW Health
|
Yes | Grant |
Employee Profiles
Number of Employee Profiles
1
AdvanCell has 1 current employee profiles, including
Board member Anthony Aiudi
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
